Novel DPP-1 Drug Trims Exacerbation Risk in Bronchiectasis

(MedPage Today) -- Targeting airway inflammation with investigational brensocatib reduced exacerbations with bronchiectasis, the ASPEN trial showed.
The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations...